Find Molsidomine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 25717-80-0, Morsydomine, Corvaton, Motazomin, Molsidolat, Sin-10
Molecular Formula
C9H14N4O4
Molecular Weight
242.23  g/mol
InChI Key
XLFWDASMENKTKL-UHFFFAOYSA-N
FDA UNII
D46583G77X

Molsidomine
A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
1 2D Structure

Molsidomine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate
2.1.2 InChI
InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3
2.1.3 InChI Key
XLFWDASMENKTKL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOC(=NC1=C[N+](=NO1)N2CCOCC2)[O-]
2.1.5 Isomeric SMILES
CCO/C(=N/C1=C[N+](=NO1)N2CCOCC2)/[O-]
2.2 Other Identifiers
2.2.1 UNII
D46583G77X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Corpea

2. Corvaton

3. Duracoron

4. Fali Cor

5. Fali-cor

6. Heumann, Molsidomin

7. Korvatone

8. Molsi 1a Pharma

9. Molsi Azu

10. Molsi Puren

11. Molsi-azu

12. Molsi-puren

13. Molsibeta

14. Molsicor

15. Molsidain

16. Molsidomin

17. Molsidomin Heumann

18. Molsidomin Ratiopharm

19. Molsidomin Stada

20. Molsidomin Von Ct

21. Molsidomin-ratiopharm

22. Molsihexal

23. Molsiket

24. Morsydomine

25. Mtw Molsidomin

26. Mtw-molsidomin

27. Sin 10

28. Sin-10

29. Sin10

30. Sydnopharm

31. Von Ct, Molsidomin

2.3.2 Depositor-Supplied Synonyms

1. 25717-80-0

2. Morsydomine

3. Corvaton

4. Motazomin

5. Molsidolat

6. Sin-10

7. Morial

8. N-ethoxycarbonyl-3-morpholinosydnonimine

9. Cas 276

10. Mls000028573

11. Sydnone Imine, N-(ethoxycarbonyl)-3-(4-morpholinyl)-

12. N-carboxy-3-morpholinosydnone Imine Ethyl Ester

13. (1e)-1-ethoxy-n-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate

14. Smr000058990

15. Sydnopharm

16. Cas-276

17. D46583g77x

18. Nsc-757398

19. N-carboxy-3-morpholinosydnonimine Ethyl Ester

20. Ncgc00015661-02

21. Cas-25717-80-0

22. N-(ethoxycarbonyl)-3-(4-morpholinyl)sydnone Imine

23. N-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]carbamic Acid Ethyl Ester

24. Sydnone Imine, N-carboxy-3-morpholino-, Ethyl Ester

25. Dsstox_cid_25171

26. Dsstox_rid_80721

27. Dsstox_gsid_45171

28. Molsidomina

29. Molsidominum

30. Covarsal

31. Molsidominum [inn-latin]

32. Molsidomina [inn-spanish]

33. Sr-05000001464

34. Einecs 247-207-4

35. Brn 3999414

36. Unii-d46583g77x

37. Ethyl (nz)-n-(3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-ylidene)carbamate

38. Molsidomine [usan:inn:ban:jan]

39. N-(ethoxycarbonyl)-3-(4-morpholino)sydnone Imine

40. Prestwick_863

41. Mfcd00869301

42. Opera_id_238

43. Molsidomine [mi]

44. Prestwick3_000547

45. Lopac-m-2901

46. Molsidomine [inn]

47. Molsidomine [jan]

48. Molsidomine [usan]

49. Molsidomine [mart.]

50. Schembl34019

51. Bspbio_000593

52. Molsidomine [who-dd]

53. Mls001146942

54. Mls002153869

55. Spectrum1500673

56. Molsidomine (jan/usan/inn)

57. Bpbio1_000653

58. Chembl1256353

59. Chembl1329455

60. Chembl4059924

61. Dtxsid0045171

62. Bdbm39912

63. Chebi:92623

64. Cid_5353788

65. Hms501o05

66. Hms1569n15

67. Hms1921a16

68. Hms2089l03

69. Hms2092g20

70. Hms2096n15

71. Hms2232f20

72. Hms2235b12

73. Hms3262a12

74. Hms3649m16

75. Hms3713n15

76. Molsidomine [ep Monograph]

77. Hy-b1069

78. Molsidomine 1.0 Mg/ml In Methanol

79. Tox21_110192

80. Tox21_500725

81. Bdbm50248123

82. Ccg-40069

83. S4664

84. Akos015843340

85. Akos015900360

86. Akos015962928

87. Akos026749793

88. Tox21_110192_1

89. Ac-7473

90. Ccg-220547

91. Cs-4625

92. Db09282

93. Ks-5160

94. Nsc 757398

95. Sdccgsbi-0050703.p005

96. Ncgc00015661-01

97. Ncgc00015661-03

98. Ncgc00015661-04

99. Ncgc00015661-05

100. Ncgc00015661-06

101. Ncgc00015661-07

102. Ncgc00015661-08

103. Ncgc00015661-09

104. Ncgc00015661-10

105. Ncgc00015661-12

106. Ncgc00015661-16

107. Ncgc00024136-03

108. Ncgc00024136-04

109. Ncgc00024136-05

110. Ncgc00024136-06

111. Ncgc00024136-07

112. Ncgc00261410-01

113. Smr001233224

114. Sbi-0050703.p004

115. Ab00513859

116. Eu-0100725

117. D01320

118. Ab00052152_14

119. Ab00513859-02

120. A817988

121. Sr-05000001464-1

122. Sr-05000001464-3

123. W-107222

124. (1e)-1-ethoxy-n-(3-morpholinooxadiazol-3-ium-5-yl)formimidate

125. (ethoxycarbonyl)(3-morpholino-1,2,3-oxadiazol-3-ium-5-yl)amide

126. 1-ethoxy-n-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate

127. (1e)-1-ethoxy-n-[3-(4-morpholinyl)-5-oxadiazol-3-iumyl]methanimidate

128. (1e)-1-ethoxy-n-(3-morpholin-4-yl-1,2,3-oxadiazol-3-ium-5-yl)methanimidate

129. (1e)-1-ethoxy-n-(3-morpholinooxadiazol-3-ium-5-yl)methanimidate;molsidomine

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 242.23 g/mol
Molecular Formula C9H14N4O4
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass242.10150494 g/mol
Monoisotopic Mass242.10150494 g/mol
Topological Polar Surface Area87 Ų
Heavy Atom Count17
Formal Charge0
Complexity270
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

The indications for use of molsidomine include ischemic heart disease, angina, chronic heart failure, and pulmonary hypertension.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Molsidomine leads to smooth muscle relaxation in the coronary blood vessels, relieving symptoms of angina and increasing blood flow to the coronary arteries.


5.2 MeSH Pharmacological Classification

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Nitric Oxide Donors

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)


5.3 ATC Code

C - Cardiovascular system

C01 - Cardiac therapy

C01D - Vasodilators used in cardiac diseases

C01DX - Other vasodilators used in cardiac diseases

C01DX12 - Molsidomine


5.4 Absorption, Distribution and Excretion

Absorption

Peak plasma drug concentration (tmax) occurs from 1 to 2 hours after administration.


Volume of Distribution

98 L


Clearance

renal excretion is the main route of elimination of the metabolites in humans (90% to 95%) About 2% of the ingested drug is excreted unchanged in the urine.


5.5 Metabolism/Metabolites

Molsidomine hepatically metabolized to _linsidomine_. Linsidomine releases nitric oxide (NO) from endothelial cells when it decays, and acts as the active vasodilating metabolite responsible for molsidomine's pharmacological effects. Oral absorption of Molsidomine is found to be 95.5% 4.5. Presystemic metabolism is noted to be 56% and metabolism is reported extensive by Liver. Renal Excretion accounts for 95 % and plasma half-life is 5 hr. Back to top


5.6 Mechanism of Action

Molsidomine, a cardiovascular drug, acts in a similar fashion to organic nitrates. The SIN-1A metabolite of molsidomine has a pharmacologically active group of nitric oxide, which increases levels of cyclic GMP, and decreases intracellular calcium ions in smooth muscle cells. This leads to relaxation of smooth muscle in the blood vessels, and inhibits platelet aggregation.


CEP/COS

read-more
read-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content
CEP 2017-021 - Rev 01
Valid
Chemical
2024-03-25
1701
Polpharma CB

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Flag Poland
Digital Content Digital Content

Certificate Number : CEP 2017-021 - Rev 01

Status : Valid

Issue Date : 2024-03-25

Type : Chemical

Substance Number : 1701

Polpharma CB

02

BIO Partnering at JPM
Not Confirmed
arrow
arrow
BIO Partnering at JPM
Not Confirmed

Certificate Number : CEP 2017-214 - Rev 01

Status : Valid

Issue Date : 2024-01-05

Type : Chemical

Substance Number : 1701

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638297000,"product":"MOLSIDOMINE PH. EUR.","address":"TORRENT HOUSE, OFF ASHRAM ROAD,","city":"AHMEDABAD","supplier":"IPOCHEM SP. Z.O.O.","supplierCountry":"POLAND","foreign_port":"N\/A","customer":"TORRENT PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"4.75","actualQuantity":"4.75","unit":"KGS","unitRateFc":"1110","totalValueFC":"5983.7","currency":"EUR","unitRateINR":"95016","date":"01-Dec-2021","totalValueINR":"451326","totalValueInUsd":"5983.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"6488657","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"","customerAddress":"TORRENT HOUSE, OFF ASHRAM ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718994600,"product":"MOLSIDOMINE","address":"TORRENT HOUSE,","city":"AHMEDABAD. GUJARAT","supplier":"POLPHARMA","supplierCountry":"POLAND","foreign_port":"WARSAW","customer":"TORRENT PHARMACEUTICALS LIMITED","customerCountry":"INDIA","quantity":"2.60","actualQuantity":"2.6","unit":"KGS","unitRateFc":"1500","totalValueFC":"4260.7","currency":"EUR","unitRateINR":"136800","date":"22-Jun-2024","totalValueINR":"355680","totalValueInUsd":"4260.7","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4125632","productDescription":"API","marketType":"REGULATED MARKET","country":"POLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"WARSAW","supplierAddress":"PELPLINSKA 19 STREET, STAROGARD GDANSKI-83-200SDNF POLAND","customerAddress":"TORRENT HOUSE,"}]
01-Dec-2021
22-Jun-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Molsidomine Manufacturers

A Molsidomine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Molsidomine, including repackagers and relabelers. The FDA regulates Molsidomine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Molsidomine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Molsidomine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Molsidomine Suppliers

A Molsidomine supplier is an individual or a company that provides Molsidomine active pharmaceutical ingredient (API) or Molsidomine finished formulations upon request. The Molsidomine suppliers may include Molsidomine API manufacturers, exporters, distributors and traders.

click here to find a list of Molsidomine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Molsidomine KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Molsidomine Drug Master File in Korea (Molsidomine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Molsidomine. The MFDS reviews the Molsidomine KDMF as part of the drug registration process and uses the information provided in the Molsidomine KDMF to evaluate the safety and efficacy of the drug.

After submitting a Molsidomine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Molsidomine API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Molsidomine suppliers with KDMF on PharmaCompass.

Molsidomine CEP

A Molsidomine CEP of the European Pharmacopoeia monograph is often referred to as a Molsidomine Certificate of Suitability (COS). The purpose of a Molsidomine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Molsidomine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Molsidomine to their clients by showing that a Molsidomine CEP has been issued for it. The manufacturer submits a Molsidomine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Molsidomine CEP holder for the record. Additionally, the data presented in the Molsidomine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Molsidomine DMF.

A Molsidomine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Molsidomine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Molsidomine suppliers with CEP (COS) on PharmaCompass.

Molsidomine GMP

Molsidomine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Molsidomine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Molsidomine GMP manufacturer or Molsidomine GMP API supplier for your needs.

Molsidomine CoA

A Molsidomine CoA (Certificate of Analysis) is a formal document that attests to Molsidomine's compliance with Molsidomine specifications and serves as a tool for batch-level quality control.

Molsidomine CoA mostly includes findings from lab analyses of a specific batch. For each Molsidomine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Molsidomine may be tested according to a variety of international standards, such as European Pharmacopoeia (Molsidomine EP), Molsidomine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Molsidomine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty